
Kevin Franck, Ph.D., M.B.A.
Chief Clinical Officer
Kevin Franck, PhD, MBA, is a leader in the inner-ear field with 25 years of expertise spanning the development, commercialization, and clinical provision of hearing-related medical products. He earned his PhD in Hearing Science from the University of Washington and his MBA in Health Care Management from the Wharton School. He is also a licensed audiologist.
Kevin’s biotech and medical device senior leadership experience spans SVP, Strategic Marketing and New Product Planning at Frequency Therapeutics, Head of Marketing at Bose Hear, Head of Clinical Products/Strategy at Cochlear, and exited his first start-up, Ear Machine. Dr. Franck was also faculty of Otolaryngology at Harvard and UPenn Schools of Medicine, and led clinical programs at Mass Eye and Ear and the Children’s Hospital of Philadelphia. He’s served on multiple national nonprofit Boards, including Chair of the Hearing Loss Association of America.
At Otolith, Kevin leads clinical and regulatory operations, leveraging his deep scientific knowledge and strong industry understanding to drive clinical success.